Cmpx stock forecast.

Look out for CMPX's next earnings release expected on November 08, 2023. For the next earning release, we expect the company to report earnings of -$0.11 per share, reflecting a year-over-year ...

Cmpx stock forecast. Things To Know About Cmpx stock forecast.

A high-level overview of Compass Therapeutics, Inc. (CMPX) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.The consensus estimate for Capital Power’s current full-year earnings is $3.23 per share. Raymond James also issued estimates for Capital Power’s Q2 2024 earnings at $0.89 EPS, Q3 2024 earnings at $1.61 EPS, Q4 2024 earnings at $1.17 EPS and FY2024 earnings at $5.27 EPS. Several other research analysts have also weighed in on the stock.Compass Therapeutics, Inc. Common Stock (CMPX) Real-time Stock Quotes - Nasdaq offers real-time quotes & market activity data for US and global markets.Analyst Forecast. According to 4 analysts, the average rating for CMPX stock is "Strong Buy." The 12-month stock price forecast is $9.33, which is an increase of 452.07% from the latest price.

It follows that stock’s current price would drop -591.82% in reaching the projected high whereas dropping to the targeted low would mean a loss of -403.14% for stock’s current value. Compass Therapeutics Inc (CMPX) estimates and forecastsAbstract. Biogenic secondary organic aerosols (SOAs) contribute to a large fraction of fine aerosols globally, impacting air quality and climate. The formation of biogenic SOA depends on not only emissions of biogenic volatile organic compounds (BVOCs) but also anthropogenic pollutants including primary organic aerosol, sulfur dioxide (SO2), …

Find the latest Compass Therapeutics, Inc. CMPX analyst stock forecast, price target, and recommendation trends with in-depth analysis from research reports.

Nov 23, 2022 · Stock Screener; ETF Screener; Comparisons; Explore Alpha Picks ... Compass Therapeutics (CMPX) Investor Presentation - Slideshow. Nov. 23, 2022 6:22 AM ET Compass Therapeutics, Inc. (CMPX) SA ... Overview News Ideas Financials Technicals Forecast CMPX chart Today 2.59% 5 days 2.06% 1 month 3.66% 6 months −31.25% Year to date −61.10% 1 year −34.44% 5 years …The 6 analysts offering 1 year price forecasts for CMPX have a max estimate of — and a min estimate of —. Analyst rating Based on 6 analysts giving stock ratings to CMPX in the past 3 months.Compass Therapeutics, Inc. Common Stock (CMPX) Real-time Stock Quotes - Nasdaq offers real-time quotes & market activity data for US and global markets.

Compass Therapeutics (CMPX) Stock Forecast & Price Target $1.72 0.00 (0.00%) (As of 01:47 PM ET) Compare Today's Range $1.68 $1.72 50-Day Range $1.40 $2.13 52-Week …

FCEL Stock 12 Months Forecast. Based on 6 Wall Street analysts offering 12 month price targets for Fuelcell Energy in the last 3 months. The average price target is $1.65 with a high forecast of $2.00 and a low forecast of $1.00. The average price target represents a 35.25% change from the last price of $1.22.

According to . 1 Wall Street analyst that have issued a 1 year PSTV price target, the average PSTV price target is $8.00, with the highest PSTV stock price forecast at $8.00 and the lowest PSTV stock price forecast at $8.00.According to our current CMPX stock forecast, the value of Compass Therapeutics shares will drop by -2.77% and reach $ 1.497361 per share by November 19, 2023. According to …CMPX Stock Price Chart Interactive Chart > Compass Therapeutics Inc. (CMPX) Company Bio. Compass Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of proprietary antibody therapeutics. immuno-oncology product candidates include a clinical-stage monoclonal antibody targeting solid tumors, a novel …Compass Therapeutics (CMPX) Stock Forecast & Price Prediction. Estimation of the future price movement of Compass Therapeutics stock, based on various factors such as …Stock Price Forecast. The 28 analysts offering 12-month price forecasts for APA Corp (US) have a median target of 48.50, with a high estimate of 65.00 and a low estimate of 34.00. The median ...

The consensus price target of analysts on Wall Street is $2.50, which implies an increase of 83.2% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $2.50 and $2.50 respectively. As a result, VGZ is trading at a discount of -495.24% off the target high and -495.24% off the low.We’ve all flipped between different weather apps, wondering why each is giving a slightly different report. Before we look at AccuWeather, it’s important to understand the basics of weather forecasting. In the past, weather predictions were...Penny stocks may sound like an interesting investment option, but there are some things that you should consider before deciding whether this is the right investment choice for you.Back to CMPX Overview. *The upcoming earnings date is derived from an algorithm based on a company's historical reporting dates. It is possible that this date will be updated in the future, once ... Stock Price Forecast. The 6 analysts offering 12-month price forecasts for Compass Minerals International Inc have a median target of 43.50, with a high estimate of 82.00 and a low estimate of 36. ...Find real-time CIX - CompX International Inc stock quotes, company profile, news and forecasts from CNN Business. APRE Stock 12 Months Forecast. $15.00. (300.00% Upside) Based on 3 Wall Street analysts offering 12 month price targets for Aprea Therapeutics in the last 3 months. The average price target is $15.00 with a high forecast of $20.00 and a low forecast of $9.00. The average price target represents a 300.00% change from the last price of $3.75.

Lastly, it’s important to evaluate a stock by comparing it against others in the same industry. Review the table below to see how Compass Therapeutics Inc. stock stands up against its competitors. Click into any of the below tickers to see their stock grades for value, momentum, quality and EPS revisions. Compass Therapeutics Inc. (CMPX ...Look out for CMPX's next earnings release expected on November 08, 2023. For the next earning release, we expect the company to report earnings of -$0.11 per share, reflecting a year-over-year ...

LGVN Stock 12 Months Forecast. $8.00. (314.51% Upside) Based on 1 Wall Street analysts offering 12 month price targets for Longeveron in the last 3 months. The average price target is $8.00 with a high forecast of $8.00 and a low forecast of $8.00. The average price target represents a 314.51% change from the last price of $1.93.Price Target Upside/Downside. According to analysts' consensus price target of $9.33, Compass Therapeutics has a forecasted upside of 465.2% from its current price of $1.65. Amount of Analyst Coverage. Compass Therapeutics has received no research coverage in the past 90 days.Find the latest Blue Water Biotech, Inc. (BWV) stock quote, history, news and other vital information to help you with your stock trading and investing.As the old saying goes, “Forewarned is forearmed.” This sentiment holds true when it comes to weather forecasting as well. One of the primary advantages of a 30-day extended weather forecast is the ability to plan ahead with confidence.In today’s fast-paced business environment, accurate forecasting is crucial for making informed decisions and staying ahead of the competition. One powerful tool that can help you achieve this is a forecasting Excel template.Nov 30, 2023 · The Compass Therapeutics, Inc. stock price gained 6.00% on the last trading day (Friday, 17th Nov 2023), rising from $1.50 to $1.59. During the last trading day the stock fluctuated 15.61% from a day low at $1.51 to a day high of $1.74. The price has fallen in 6 of the last 10 days and is down by -14.52% for this period. According to the issued ratings of 4 analysts in the last year, the consensus rating for Catalyst Pharmaceuticals stock is Buy based on the current 4 buy ratings for CPRX. The average twelve-month price prediction for Catalyst Pharmaceuticals is $24.75 with a high price target of $27.00 and a low price target of $24.00.

Latest CMPS News. View. COMPASS Pathways (CMPS, $5.98) entered Downtrend as Momentum indicator drops below 0 level on Nov 30, 2023. Tickeron - Stocks • 3 days ago. Compass Pathways to participate in upcoming Evercore investor conference. Globe Newswire • 10 days ago.

Stock Price Forecast. The 6 analysts offering 12-month price forecasts for Compass Minerals International Inc have a median target of 43.50, with a high estimate of 82.00 and a low estimate of 36. ...

Compass Therapeutics Inc. analyst ratings, historical stock prices, earnings estimates & actuals. CMPX updated stock price target summary. CMPX stock forecast Our latest prediction for Compass Therapeutics Inc's stock price was made on the March 15, 2023 when the stock price was at 3.56$. In the short term (2weeks), CMPX's stock price should underperform the market by -2.94%. During that period the price should oscillate between -8.72% and +5.46%.Compass Therapeutics Inc (CMPX) stock price, GURU trades, performance, financial stability, valuations, and filing info from GuruFocus. 🚀 Enjoy a 7-Day Free Trial Thru Dec 01, 2023! Sign UpComplix' Alphabody™ Protein Therapeutics Demonstrate Activity against both Undruggable Extracellular and Intracellular Disease TargetsSee the latest Compass Therapeutics Inc Ordinary Shares stock price (NASDAQ:CMPX), related news, valuation, dividends and more to help you make your investing decisions.Find the latest Capital Power Corporation (CPX.TO) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W ...From AI system, total return is 2366.52% from 4098 forecasts. For CompX International stock forecast for 2023, 1 predictions are offered for each month of 2023 with average CompX International stock forecast of $20.52, a high forecFind the latest Compass Therapeutics, Inc. (CMPX) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.March 7, 2024. EPS forecast (this quarter) $0.30. Annual revenue (last year) $378.5M. Annual profit (last year) $18.7M. Net profit margin. View NASDAQ COMPOSITE COMPX investment & stock information. Get the latest NASDAQ COMPOSITE COMPX detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.The average one-year price target for CMPX / Compass Therapeutics Inc is $9.35. The forecasts range from a low of $8.08 to a high of $11.55. A stock’s price target is the price at which analysts consider it fairly valued with respect to its projected earnings and historical earnings.SFIX Stock 12 Months Forecast. $3.68. (5.75% Upside) Based on 10 Wall Street analysts offering 12 month price targets for Stitch Fix in the last 3 months. The average price target is $3.68 with a high forecast of $5.00 and a low forecast of $2.50. The average price target represents a 5.75% change from the last price of $3.48.

Find the latest OPKO Health, Inc. (OPK) stock quote, history, news and other vital information to help you with your stock trading and investing.Based on short-term price targets offered by seven analysts, the average price target for Compass Therapeutics, Inc. comes to $9.33. The forecasts range from a low of $8.00 to a high of $11.00 ... The Compass Therapeutics, Inc. stock price gained 2.42% on the last trading day (Friday, 1st Dec 2023), rising from $1.65 to $1.69. During the last trading …Greenlane Holdings, Inc. (NASDAQ:GNLN) released its earnings results on Monday, November, 15th. The company reported ($46.00) earnings per share for the quarter, missing the consensus estimate of ($14.00) by $32.00. The company had revenue of $41.31 million for the quarter, compared to analyst estimates of $40.31 million.Instagram:https://instagram. bmw.740fisher financial advisors reviewsmeaning of betaarm ipo prospectus CMPX Stock Predictions. CMPX Stock Buy or Sell? - Get a free CMPX stock trend analysis report to help you analyze and make a better CMPX stock predictions. The stock analysis service is provided by MarketClub, using their Smart Scan and Trade Triangle technology. It uses technical analysis and the current market condition to give you the best ...Stock Screener; ETF Screener; Comparisons; Explore Alpha Picks ... Compass Therapeutics (CMPX) Investor Presentation - Slideshow. Nov. 23, 2022 6:22 AM ET Compass Therapeutics, Inc. (CMPX) SA ... what gold stock to buystock price of devon energy Mind Medicine (MNMD) is a biotech company that develops psychedelic-inspired therapies for mental health disorders. Find out how analysts rate the stock and what are its growth prospects on TipRanks.com. You can also access the latest earnings reports, forecasts, and price movements of MNMD on the same platform.---Don't miss this opportunity to …Find the latest Blue Water Biotech, Inc. (BWV) stock quote, history, news and other vital information to help you with your stock trading and investing. gm stock forecast Nov 18, 2023 · It follows that stock’s current price would drop -591.82% in reaching the projected high whereas dropping to the targeted low would mean a loss of -403.14% for stock’s current value. Compass Therapeutics Inc (CMPX) estimates and forecasts Weather forecasting plays a crucial role in our daily lives, helping us plan our activities and make informed decisions. But have you ever wondered how meteorologists are able to accurately predict the weather? One of the key components in ...Aeterna Zentaris (TSE:AEZS) Forecast: Is this specialty biopharmaceutical company a good stock to buy? Find out the latest analysis, ratings, and price targets from TipRanks, the leading platform for financial insights.